General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-15 | 2024-03 | -0.37 | -0.36 | 0.01 | 2.70% |
2024-04-01 | 2023-12 | -0.52 | -1.06 | -0.54 | -103.85% |
2023-11-14 | 2023-09 | 0 | -0.57 | N/A | N/A |
2023-08-14 | 2023-06 | -0.45 | -0.69 | -0.24 | -53.33% |
2023-05-15 | 2023-03 | -0.85 | -0.81 | 0.04 | 4.71% |
2023-03-30 | 2022-12 | 0 | -0.73 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-05-16 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
2023-03-30 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-30 | JMP Securities | Upgrade | Market Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-12-16 | APPLEBAUM SCOTT | Officer | 365.20K | Stock Award(Grant) |
2023-12-13 | BOURDOW CARRIE L | Chief Executive Officer | 642.92K | Stock Award(Grant) |
2023-12-13 | DEMITRACK MARK A | Officer | 306.22K | Stock Award(Grant) |
2023-12-13 | DRAKE PATRICIA M | Officer | 107.08K | Stock Award(Grant) |
2019-01-31 | GOWEN MAXINE | Chief Executive Officer | 470.01K | Purchase |
2018-03-21 | HABIB YACOUB PH.D. | Officer | 0.00 | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Renaissance Technologies, LLC | 182.15K | 160.48K | 1.33% |
2023-06-29 | Blackrock Inc. | 112.17K | 98.82K | 0.82% |
2023-06-29 | Vanguard Group Inc | 72.81K | 64.15K | 0.53% |
2023-06-29 | Geode Capital Management, LLC | 65.17K | 57.41K | 0.48% |
2023-06-29 | Simplex Trading, LLC | 37.59K | 33.12K | 0.27% |
2023-06-29 | Captrust Financial Advisors | 33.08K | 29.14K | 0.24% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 70.18K | 61.83K | 0.51% |
2023-05-30 | Fidelity Extended Market Index Fund | 33.10K | 37.73K | 0.24% |
2023-08-30 | Fidelity OTC Portfolio | 17.81K | 15.49K | 0.13% |
2023-05-30 | Fidelity Total Market Index Fund | 8.95K | 10.20K | 0.07% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 7.46K | 8.50K | 0.05% |
2023-05-30 | Fidelity Series Total Market Index Fund | 7.36K | 8.39K | 0.05% |
Split | Date |
---|---|
1 : 25 | 2022-11-10 |
If the people buying the stock have more knowledge than the TRVN CEO ,on how to run a company, than we are pretty fuckeddd
Shut your trap @derek , with all this bullshit
Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer, will participate in a fireside chat at the JMP Securities CNS Forum, being held virtually on August 19 – 20, 2020.
TRVN Uptrend daily charts
Look I am a rookie trader and even I know how important this drug is.
You will regret selling this one day
$TRVN will be fine. Hold strong and be patient.
I’m holding strong but damn this is testing my rookie ass. Trying to be intelligent about it and be strong.
Earnings after market?
More volume but it’s not going up whyyy?
My stop loss kicked in this morning and I said screw that action! I bought back!
Congratulations to all!!!
Looks like it closes below $2.5